EMA Withdrawn: Infergen (interferon alfacon-1) — Astellas Pharma Europe B.V.

View source ↗

Summary

Infergen (interferon alfacon-1) has been withdrawn by Astellas Pharma Europe B.V. for chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Infergen (interferon alfacon-1)

Snippet

Status: Withdrawn. Therapeutic area: Hepatitis C, Chronic. MAH: Astellas Pharma Europe B.V.. Decision date: 05/05/2006